Evaluation of Plasma Opioid and Serum Lipocalin-2 Levels in Pruritic Skin Diseases
The present results suggest that the ratio of plasma opioids is involved in itch control in AsD patients, and serum LCN-2 levels may be a biomarker for itch and its severity in those with PSO.
Authors
- Nobuaki Takahashi (ORCID: https://orcid.org/0000-0001-8802-301X)
- Catharina Sagita Moniaga
- Mitsutoshi Tominaga (ORCID: https://orcid.org/0000-0002-1254-1803)
- Yasushi Suga (ORCID: https://orcid.org/0000-0003-3643-2879)
- Kenji Takamori (ORCID: https://orcid.org/0000-0002-0644-0504)
- MAYU KAWAMURA (ORCID: https://orcid.org/0009-0003-2754-6732)
- Yayoi Kamata (ORCID: https://orcid.org/0000-0002-3477-5715)
- Takahide Kaneko (ORCID: https://orcid.org/0000-0002-6219-6665)
- Eriko Komiya (ORCID: https://orcid.org/0000-0002-7450-1188)
Institutions
- Juntendo University (JP)
- Juntendo University Urayasu Hospital (JP)
Publication Details
- Journal
- Juntendo Medical Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.14789/ejmj.jmj24-0043-oa
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00